Table 2 Mitotic timings in mouse embryos injected with cyclin B1-Ruby.

From: Delayed APC/C activation extends the first mitosis of mouse embryos

Experimental conditions

Total no.

Time between NEBD and cyclin B1 degradation (min; median (Q1; Q3))

Time between NEBD and anaphase (min; median (Q1; Q3))

1-cell

control

55

48.0 (40.5; 52.5)

96.0 (87.0; 105.0)

reversine

57

39.0 (30.0; 45.0)b

87.0 (81.0; 96.0)

wt Plk1 OE

38

28.5 (24.0; 33.0)a

78.0 (75.0; 92.3)a

kd Plk1 OE

11

45.0 (39.0; 51.0)

87.0 (82.5; 99.0)

BI2536

12

93.0 (83.3; 100.5)b

—

BI2536 + reversine

15

90.0 (87.0; 103.5)b

—

cyclin A2 OE (0.07 µg/µl)

41

48.0 (45.0; 51.0)

115.5 (105.8; 128.3)a

cyclin A2 OE (0.2 µg/µl)

12

54.0 (44.3; 60.8)

117.0 (111.0; 135.0)e

cyclin A2 OE (0.4 µg/µl)

10

54.0 (51.8; 67.5)

—

2-cell

control

31

18.0 (15.0; 24.0)a,c

76.5 (69.8; 81.0)a,d

  1. ap < 0.001 comparing to control 1-cell embryos,
  2. bp < 0.05 comparing to control 1-cell embryos,
  3. cp < 0.001 comparing to reversine-treated 1-cell embryos,
  4. dp < 0.05 comparing to reversine-treated 1-cell embryos,
  5. evalues calculated only for embryos that completed cytokinesis (9 out of 12).